Cardiovascular Disease, Atherosclerosis and Familial Hypercholesterolemia: From Molecular Mechanisms Causing Pathogenicity to New Therapeutic Approaches

Shifa Jebari-Benslaiman; Asier Larrea-Sebal; Asier Benito-Vicente; César Martín

doi:10.3390/ijms24087659

Cardiovascular Disease, Atherosclerosis and Familial Hypercholesterolemia: From Molecular Mechanisms Causing Pathogenicity to New Therapeutic Approaches

Int J Mol Sci. 2023 Apr 21;24(8):7659. doi: 10.3390/ijms24087659.

Authors

Shifa Jebari-Benslaiman^{1

2}, Asier Larrea-Sebal^{1

2

3}, Asier Benito-Vicente^{1

2}, César Martín^{1

2}

Affiliations

¹ Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, 48080 Bilbao, Spain.
² Department of Molecular Biophysics, Biofisika Institute, University of Basque Country and Consejo Superior de Investigaciones Científicas (UPV/EHU, CSIC), 48940 Leioa, Spain.
³ Fundación Biofisika Bizkaia, 48940 Leioa, Spain.

Abstract

This Special Issue, "Cardiovascular Disease, Atherosclerosis and Familial Hypercholesterolemia: From Molecular Mechanisms Causing Pathogenicity to New Therapeutic Approaches", contributes to advancing our knowledge of the molecular mechanisms that drive cardiovascular disease, atherosclerosis and familial hypercholesterolemia and the development of state-of-the-art research in the field [...].

Publication types

Editorial

MeSH terms

Atherosclerosis* / drug therapy
Atherosclerosis* / etiology
Cardiovascular Diseases* / complications
Humans
Hyperlipoproteinemia Type II* / complications
Hyperlipoproteinemia Type II* / genetics
Hyperlipoproteinemia Type II* / therapy
Virulence